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Rab7 Prevents Growth Factor-Independent
Survival by Inhibiting Cell-Autonomous
Nutrient Transporter Expression
may directly regulate the uptake of extracellular nutri-
ents by controlling nutrient transporter expression. Al-
though this decline in nutrient uptake could result from
a decrease in cellular demand due to the loss of growth
factor stimulation of cell growth, growth factor with-
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drawn cells exhibit characteristics of starvation, such as
cellular atrophy and autophagic proteolysis. This growth
factor withdrawal-induced state of pseudostarvationSummary
produced by nutrient transporter downregulation may
provide the trigger for subsequent apoptosis by affect-Growth factor withdrawal results in the endocytosis
ing cellular bioenergetics. Alterations in mitochondrialand degradation of transporter proteins for glucose
metabolism, reflected by decreases in the mitochondrialand amino acids. Here, we show that this process is
membrane potential, precede the changes in mitochon-under the active control of the small GTPase Rab7. In
drial physiology that ultimately result in the release ofthe presence of growth factor, Rab7 inhibition had no
proapoptotic mediators (Vander Heiden et al., 1997,effect on nutrient transporter expression. In growth
1999). Activated forms of the protooncogene Akt sup-factor-deprived cells, however, blocking Rab7 func-
port growth factor-independent survival and preservetion prevented the clearance of glucose and amino
the mitochondrial membrane potential through a mecha-acid transporter proteins from the cell surface. When
nism that depends on the availability of extracellularRab7 was inhibited, growth factor deprived cells main-
nutrients and on the continued expression of nutrienttained their mitochondrial membrane potential and
transporters on the cell surface (Cantley and Neel, 1999;displayed prolonged, growth factor-independent, nu-
Edinger and Thompson, 2002; Gottlob et al., 2001; Plastrient-dependent cell survival. Thus, Rab7 functions
et al., 2001). These results suggest that the antiapoptoticas a proapoptotic protein by limiting cell-autonomous
potential of Akt is closely tied to its ability to promotenutrient uptake. Consistent with this, dominant-nega-
growth factor-independent nutrient uptake.tive Rab7 cooperated with E1A to promote the trans-
Following endocytosis, cell surface proteins enter ei-formation of p53/ mouse embryonic fibroblasts
ther a degradative or a recycling pathway (Mellman,(MEFs). These results suggest that proteins that limit
1996). Proteins targeted to the degradative pathwaynutrient transporter expression function to prevent
transit through the multivesicular body and ultimatelycell-autonomous growth and survival.
enter the lysosome where they are subject to proteolytic
degradation. It has been suggested that proteins thatIntroduction
are not explicitly tagged for degradation enter a default,
recycling pathway and are reexpressed on the cell sur-A requirement for multicellularity is that cellular growth
face. One of the proteins involved in this sorting processis constrained within the limits of tissue homeostasis.
is the small GTPase Rab7. Rab7 catalyzes late endo-Unlike unicellular eukaryotes, the proliferation of mam-
some-lysosome (heterotypic) and lysosome-lysosomemalian cells is not determined by the availability of extra-
(homotypic) membrane fusion reactions through acellular nutrients. Rather, mammalian cells are con-
mechanism that is incompletely understood (Bucci etstantly supplied with nutrients and cell growth is
al., 2000; Feng et al., 1995). Thus, Rab7 has a positivecontrolled through cellular dependence on extrinsic fac-
role in the degradation of plasma membrane proteins.
tors produced by other cells (Conlon and Raff, 1999;
If nutrient transporter downregulation sets up a state
Raff, 1992). These growth factors provide signals that
of pseudostarvation that ultimately results in the initia-
allow cells to survive, divide, and accumulate mass. tion of apoptosis, then interfering with the internalization
When growth factors become limiting, cells withdraw and degradation of these transporter proteins should
from the cell cycle, atrophy, and undergo apoptosis via protect cells from growth factor withdrawal-induced cell
an intrinsic cell death pathway initiated by mitochondria. death. To test whether the rapid atrophy, decline in
Thus, growth factor dependence represents an impor- cellular bioenergetics, and programmed cell death asso-
tant obstacle to neoplastic transformation. Tumor cells ciated with growth factor withdrawal was directly
must acquire mutations that allow them to avoid apopto- caused by or merely correlated with the loss of access
sis and to proliferate in the absence of extrinsic signals. to extracellular nutrients due to transporter downregula-
When cells are withdrawn from growth factors, the tion, we prevented the degradation of nutrient transport-
rates of glucose and amino acid uptake decline rapidly ers by interfering with the function of Rab7. Consistent
(Edinger and Thompson, 2002; Kan et al., 1994; Vander with the hypothesis that nutrient transporter downregu-
Heiden et al., 2001; Whetton et al., 1984). In addition, lation plays a causative role in these processes, the
transporters for iron (transferrin receptor) and choles- inhibition of Rab7 function resulted in a nutrient-replete
terol (LDL receptor) are also rapidly lost from the surface cellular phenotype despite growth factor withdrawal. In
of growth factor-deprived cells (Edinger and Thompson, addition, cells in which nutrient transporter expression
2002). These observations suggest that growth factors was supported by blocking Rab7 function displayed
long-term resistance to growth factor withdrawal-
induced cell death but were as sensitive as control cells*Correspondence: craig@mail.med.upenn.edu
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to apoptosis induced by nutrient limitation. Interfering
with the function of the downstream protein RILP also
protected cells from growth factor withdrawal-induced
cell death, suggesting that other proteins in this pathway
may also regulate growth factor withdrawal-induced
apoptosis. Furthermore, disrupting Rab7 function facili-
tated the transformation of p53/ MEFs by E1A. These
results suggest that Rab7 contributes to the control of
cellular growth by limiting the ability of cells to take up
extracellular nutrients in a cell-autonomous fashion.
Results
Nutrient Transporter Expression Is Maintained
following Growth Factor Withdrawal When
Rab7 Function Is Inhibited
Dominant-negative forms of many GTPases can be pro-
duced through point mutations in the GTP binding do-
main (Feng et al., 1995). The point mutation T22N in the
GTP binding domain of Rab7 produces such a domi-
nant-negative protein (Feng et al., 1995; Vitelli et al.,
1997). When Rab7 T22N is expressed in fibroblasts, het-
erotypic and homotypic lysosomal fusion reactions are
inhibited and plasma membrane proteins are recycled
to the cell surface rather than degraded in lysosomes
(Bucci et al., 2000; Feng et al., 1995; Vitelli et al., 1997).
We stably expressed Rab7 T22N in FL5.12 cells, a mu-
rine hematopoetic cell line. The FL5.12 cell line was
selected for these studies because it is dependent on
a defined growth factor, IL-3, for growth and survival.
For ease in detection and screening, we expressed Rab7
T22N as an N-terminal EGFP fusion protein (Bucci et
al., 2000).
FL5.12 cell clones stably expressing Rab7 T22N were
screened by flow cytometry for EGFP expression. Two
Figure 1. Dominant-Negative Rab7 Can Be Stably Expressed inlines expressing high levels of EGFP were labeled T22N
Growth Factor-Dependent Cells1 and T22N 2 and used for further analyses. These lines
(A) Rab7 T22N was stably expressed in FL5.12 cells as an N-terminalwere screened by Western blot to evaluate Rab7 T22N
EGFP fusion protein. Two clones expressing Rab7 T22N at a similarexpression level (Figure 1A). EGFP-Rab7 T22N was ex-
level to the endogenous protein, T22N 1 and T22N 2, were selectedpressed in both lines at approximately the same level
for further studies.
as endogenous Rab7. The inhibition of Rab7 function (B) FL5.12 cells stably expressing Rab7 T22N or empty vector were
had no effect on cell growth under normal culture condi- stained with LysoTracker Red to evaluate lysosomal morphology.
tions consistent with the observation that the cloning Apparent differences in cell diameter reflect the relative extent
of cell flattening by the coverslip rather than true differences inefficiency for Rab7 T22N and empty vector was equiva-
cell size.lent (data not shown). To confirm that this level of Rab7
T22N was sufficient to interfere with the function of en-
dogenous Rab7, lysosomal morphology was evaluated Bcl-XL was coexpressed with Rab7 T22N. Bcl-XL pre-
(Figure 1B and data not shown). Lysosomal fragmenta- vents cell death upon growth factor withdrawal but does
tion was observed in T22N 1 and T22N 2, confirming not interfere with nutrient transporter downregulation
that Rab7 function was inhibited in these clones. (Plas et al., 2001; Rathmell et al., 2000; Vander Heiden
The Rab7 dependence of growth factor withdrawal- et al., 2001; and A.L.E., R.M.C., and C.B.T., unpublished
induced degradation of 4F2hc and Glut1 was evaluated. data). Thus, transporter turnover can be examined in
The amino acid transporter-associated protein 4F2hc the absence of the confounding effects of cell death
was selected for these studies as few mammalian amino through the coexpression of Bcl-XL.
acid transporters have been molecularly cloned, and In control cells maintained in IL-3, 4F2hc was found
antibodies to these proteins are not readily available primarily on the cell surface (Figure 2A). When IL-3 was
(Palacin et al., 1998). 4F2hc forms a heterodimeric com- withdrawn from these cells, bright intracellular spots of
plex with a variety of light chains, directing these pro- 4F2hc staining developed. Interfering with Rab7 function
teins to the cell surface where they transport cationic had no effect on 4F2hc expression in the presence of
amino acids (Deves and Boyd, 2000; Palacin et al., 1998). growth factor. However, when growth factor was with-
Consistent with its role in amino acid uptake, 4F2hc is drawn, focal intracellular staining for 4F2hc did not de-
an early activation marker in lymphocytes and is highly velop in Rab7 T22N-expressing cells. Rather, many
expressed on a variety of tumor cells. To perform immu- small spots of 4F2hc staining were apparent. These re-
sults are consistent with an intact endocytic pathwaynofluorescence studies on cells withdrawn from IL-3,
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Figure 2. Rab7 Function Is Required for Degradation of the Amino Acid Transport-Associated Protein 4F2hc and Glut1 in Response to Growth
Factor Withdrawal
(A) Control cells expressing Bcl-XL or cells also expressing Rab7 T22N were maintained in the presence or absence of IL-3 as indicated for
24 hr then fixed and stained for 4F2hc expression. Scale bar represents 10 m. Insets show a single cell magnified to more clearly visualize
the staining pattern.
(B) FL5.12 cells stably expressing empty vector or a short hairpin directed against Rab7 (shRab7) were withdrawn from IL-3 for 14 hr and
4F2hc and Lamp-1 colocalization evaluated by confocal microscopy.
(C) Cells were prepared as in (A), stained for surface 4F2hc expression at 48 hr, and analyzed by flow cytometry. Analysis was restricted to
live cells. One of three similar experiments is shown.
(D) To investigate the changes in Glut1 expression in response to IL-3 withdrawal, control cells expressing Bcl-XL or cells also expressing
Rab7 T22N were maintained in the presence or absence of IL-3 for the indicated intervals, lysed, and Glut1 protein levels determined by
Western blot. Ten micrograms of total protein isolated from purified live cells were loaded in each lane. Based on densitometry, there was a
nearly 2-fold difference in the degree of decline in Glut1 levels between control and T22N-expressing cells. In addition, the electrophoretic
mobility of the remaining Glut1 was distinctly different in the two cell lines. One of three similar experiments is shown.
but a defect in endosome-lysosome fusion as has been Rab7 inhibition did not affect the surface expression of
4F2hc. When IL-3 was withdrawn from control cells, areported in other cell types expressing Rab7 T22N.
To confirm that interfering with Rab7 function de- decrease in 4F2hc surface staining was readily appar-
ent. When Rab7 function was blocked, however, thecreased the trafficking of 4F2hc to lysosomes upon IL-3
withdrawal, levels of endogenous Rab7 were reduced loss of surface 4F2hc molecules following IL-3 with-
drawal was largely prevented.by RNAi, and the localization of 4F2hc and the lysosomal
membrane protein Lamp-1 were evaluated in IL-3 with- The degradation of Glut1 was also evaluated. Glut1
is the major glucose transporter expressed in FL5.12drawn FL5.12 cells by confocal microscopy (Figure 2B).
While intracellular 4F2hc and Lamp-1 colocalized in con- cells. Control cells and cells expressing Rab7 T22N were
maintained in or withdrawn from IL-3 for the indicatedtrol cells deprived of growth factor, 4F2hc and Lamp-1
staining did not overlap in IL-3 withdrawn cells express- times and Glut1 content as a percentage of total cell
protein evaluated by Western blot (Figure 2D). In theing reduced levels of Rab7.
To verify that the defect in lysosomal fusion resulting presence of IL-3, interfering with Rab7 function had no
effect on Glut1 expression levels. Following growth fac-from Rab7 inhibition translated into increased surface
expression of 4F2hc, vector control and Rab7 T22N- tor deprivation, Glut1 levels steadily declined in control
cells. However, inhibiting Rab7 impeded Glut1 degra-expressing cells were analyzed for surface 4F2hc levels
by flow cytometry (Figure 2C). In the presence of IL-3, dation.
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Glut1 is heterogeneously glycosylated and does not leads to a catabolic state in which cells are forced to
digest their constituent proteins for energy productionrun as a discrete band in SDS-PAGE gels (Mueckler,
1994). Interestingly, Glut1 from Rab7 T22N-expressing (Rathmell et al., 2000, 2001; Vander Heiden et al., 2001).
It was possible that blocking Rab7-dependent nutrientcells includes a population of proteins with decreased
mobility in SDS-PAGE. This low-mobility form of Glut1 transporter degradation would prevent this catabolic
atrophy. We therefore evaluated whether Rab7 T22Nbecomes the dominant form in Rab7 T22N-expressing
cells following growth factor withdrawal. Studies of pro- expression affected the cellular atrophy associated with
IL-3 withdrawal. Cell size was measured by flow cytome-tein trafficking have shown that glycoproteins in the
recycling pathway can reenter the TGN and trans-Golgi try. Analysis was restricted to live G1 cells by gating on
propidium iodide-negative cells with a 2N DNA content,where their glycosylations can be remodeled (Snider
and Rogers, 1985, 1986; Volz et al., 1995). One possibility to eliminate the confounding effects of cell cycle posi-
tion on cell size. In the presence of IL-3, blocking Rab7was that increased recycling of Glut1 in Rab7 T22N-
expressing cells led to increased glycosylation due to function did not affect cell size (Figure 3C). Following
24 hr of IL-3 withdrawal, a reduction in the size of livereiterative trips through the Golgi. To determine whether
the observed differences in protein mobility resulted G1 cells was observed in all cell lines. However, interfer-
ing with Rab7 function resulted in decreased cellularfrom differences in glycosylation, Glut1 was immunopre-
cipitated from vector control or Rab7 T22N-expressing atrophy relative to vector control cells.
Growth factor withdrawal also leads to a decline incells in the presence and absence of growth factor and
digested with endoglycosidase F (Endo F). Removal of the mitochondrial membrane potential (Vander Heiden
et al., 1999). One possible explanation for the decreaseglycosylated residues by Endo F treatment produced a
single, faster migrating species of Glut1 in both vector in m is a reduction in the rate of electron transport
due to the decreased uptake of oxidizable metabolites.control and Rab7 T22N-expressing cells (data not
shown). These results indicate that the decreased mobil- The mitochondrial membrane potential was measured
by TMRE fluorescence in vector control and Rab7ity of Glut1 in Rab7 T22N-expressing cells resulted from
differential glycosylation and support the conclusion T22N-expressing cells in the presence of IL-3 or after
growth factor withdrawal (Figure 3D). Blocking Rab7that interfering with Rab7 function increased the recy-
cling of plasma membrane proteins. function did not affect m in growth factor-replete
cells. As expected, m decreased in vector control cells
following IL-3 withdrawal. In contrast, cells expressingCells Maintain a Nutrient-Replete Phenotype
Rab7 T22N maintained their mitochondrial membrane po-Despite Growth Factor Withdrawal When
tential despite IL-3 withdrawal. In summary, increasedRab7 Is Inhibited
4EBP1 phosphorylation, decreased cellular atrophy, andWe next wished to determine whether the decreased
maintenance of the mitochondrial membrane potentialdegradation and increased recycling of nutrient trans-
following growth factor withdrawal suggest that nutrientporters that resulted from blocking Rab7 function pre-
uptake is maintained when Rab7-dependent nutrientvented the induction of a starvation-like state following
transporter degradation is prevented.growth factor withdrawal. For this reason, 4EBP1 phos-
phorylation was evaluated by Western blot. The mTOR
kinase responds to intracellular amino acids levels, ex- IL-3 Signaling Is Not Maintained When Rab7
Function Is Inhibitedhibiting increased activity in the presence of amino acids
and decreased activity when amino acids are withdrawn One possible explanation for the ability of Rab7 T22N
to support growth factor-independent nutrient uptake(Raught et al., 2001; Rohde et al., 2001; Schmelzle and
Hall, 2000). The rate of cap-dependent translation is is that, by blocking Rab7 function, the degradation of
the ligand-bound IL-3 receptor is inhibited leading tocontrolled by mTOR through the regulation of 4EBP1
phosphorylation. mTOR maintains 4EBP1 in the phos- persistent IL-3 signaling despite removal of IL-3 from
the medium. To assess whether IL-3 mediated signalphorylated state, rendering it incompetent to bind eIF4E,
allowing the formation of the eIF4F complex and thereby transduction is affected by the inhibition of Rab7, we
evaluated whether Rab7 T22N expression preservedincreasing the rate of cap-dependent translation. 4EBP1
is phosphorylated at multiple sites and is therefore de- Pim-1 protein levels or Akt phosphorylation in the ab-
sence of IL-3. Pim-1 is an IL-3 responsive protein withtected as a series of bands with distinct mobilities in
SDS-PAGE. The inhibition of Rab7 had no effect on a short half-life that disappears rapidly following IL-3
withdrawal (Hoover et al., 2001; Lacronique et al., 2000;4EBP1 phosphorylation in the presence of growth factor
(Figure 3A). As expected, 4EBP1 was rapidly dephos- Morcinek et al., 2002; Nieborowska-Skorska et al., 2002;
Nosaka et al., 1999; Nosaka and Kitamura, 2002). Pim-1phorylated in vector control cells withdrawn from IL-3.
When Rab7 activity was blocked, however, 4EBP1 phos- is present in FL5.12 cells as two proteins of 34 and 44
kDa due to alternate translational start sites. Regardlessphorylation was partially maintained (Figure 3A). 4EBP1
phosphorylation persisted in Rab7 T22N-expressing of whether or not Rab7 function was inhibited, the Pim-1
protein was rapidly lost following growth factor depriva-cells for at least 48 hr after growth factor withdrawal
(Figure 3B). Rab7 T22N-supported 4EBP1 phosphoryla- tion (Figure 4A). The phosphorylation and activation of
the serine/threonine kinase Akt is also regulated by IL-3.tion was sensitive to treatment with the mTOR inhibitor
rapamycin, consistent with the proposal that sustained When IL-3 is withdrawn, Akt phosphorylation at the key
regulatory sites Thr308 and Ser473 declines (Figure 4B).mTOR activity was responsible for the maintenance of
4EBP1 phosphorylation (data not shown). Interfering with Rab7 function did not maintain Akt phos-
phorylation in the absence of IL-3. Thus, the effects ofIt has been suggested that decreased extracellular
nutrient uptake following the loss of trophic support Rab7 T22N expression cannot be attributed to sustained
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Figure 3. Cells Expressing Dominant-Negative Rab7 Maintain a Nutrient-Replete Phenotype Despite Growth Factor Deprivation
(A) Vector control cells or cells expressing Rab7 T22N were withdrawn from IL-3 for the indicated times, lysed, and 4EBP1 phosphorylation
determined by Western blot using a phosphospecific 4EBP1 antibody. Fifty micrograms of total protein was loaded in each lane.
(B) Cells expressing Bcl-XL or cells also expressing Rab7 T22N were prepared as in (A), but withdrawn from IL-3 for longer intervals. Both
phospho- and total 4EBP1 levels were evaluated by Western blot.
(C) Cell lines expressing the indicated transgenes were withdrawn from IL-3 for 24 hr and cell size determined by flow cytometry. Analysis
was restricted to live G1 cells by gating on propidium iodide-negative cells with a 2N DNA content. One of three similar experiments is shown.
Error bars represent SD; VEC, vector.
(D) Vector control or Rab7 T22N-expressing cells were maintained in or withdrawn from IL-3 for 14 hr as indicated and mitochondrial membrane
potential evaluated by TMRE staining and flow cytometry. m was dissipated by the addition of CCCP and chloroquine (CQ). One of three
similar experiments is shown.
Akt activation. Taken together, these results demon- transporter downregulation, then interfering with Rab7
strate that Rab7 T22N expression does not result in function should increase cell survival following growth
persistent IL-3 signaling in the absence of ligand. factor withdrawal. To test this prediction, the ability of
Rab7 T22N to protect FL5.12 cells from IL-3 withdrawal-
induced apoptosis was measured (Figure 5A). VectorBlocking Rab7-Dependent Nutrient Transporter
control cells died with the expected kinetics upon IL-3Degradation Confers Growth Factor-Independent,
withdrawal. When Rab7 function was blocked, however,Nutrient-Dependent Cell Survival
cells exhibited long-term, IL-3-independent survival.If growth factor withdrawal-induced apoptosis results
from a state of pseudostarvation induced by nutrient FL5.12 cells expressing similar levels of wild-type Rab7
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T22N expression was specific to its interference with
Rab7 function, we evaluated the effect on cell survival
of reducing Rab7 levels by RNAi. Rab7 levels were de-
creased in FL5.12 cells following the transient expres-
sion of DNA designed to produce a short RNA hairpin
targeted against murine Rab7 (Figure 6A). When these
cells were withdrawn from IL-3, cell survival was in-
creased (Figure 6B) and cellular atrophy was decreased
(Figure 6C), consistent with the results obtained with
the dominant-negative construct. Furthermore, cotrans-
fection of wild-type canine Rab7 eliminated the effect
of the hairpin targeted against the murine sequence,
demonstrating that the increases in cell survival and
size resulted from the loss of the endogenous Rab7
protein. The ability of Rab7 T22N expression and re-
duced Rab7 protein levels to protect from growth factor
withdrawal-induced apoptosis strongly suggests that
the Rab7-dependent degradation of nutrient transport-
ers contributes to the initiation of growth factor with-
drawal-induced apoptosis.
Based on the results obtained with Rab7, we wished
to determine whether other proteins in the lysosomal
degradation/recycling pathway might also have proapo-
ptotic effects. RILP interacts with Rab7 and may func-
tion downstream of this protein by recruiting minus end
directed dynein-dynactin containing motor complexes
to late endosomes and lysosomes (Cantalupo et al.,
2001; Jordens et al., 2001). N-terminally truncated forms
of RILP function as dominant-negative proteins and
produce fragmentation of the lysosomal compartment
similar to dominant-negative Rab7 constructs. An N-ter-
minally truncated form of RILP (C33 RILP) was expressed
Figure 4. Interfering with Rab7 Activity Does Not Result in Sustained in FL5.12 cells, resulting in lysosomal fragmentation as
IL-3 Mediated Signaling following Growth Factor Withdrawal evaluated by LysoTracker Red staining (Figure 6D and
(A) Control Bcl-XL-expressing cells or cells also expressing Rab7 data not shown). Similar to results obtained in Rab7
T22N were maintained in the presence or absence of IL-3 as indi-
T22N-expressing cells, C33 RILP expression resulted incated, lysed, and Pim-1 and actin expression levels evaluated by
long-term, dose-dependent cell survival in the absenceWestern blot. Equal amounts of total cell protein were loaded in
each lane. of growth factor (Figure 6E). Both C33 RILP-expressing
(B) Cells were prepared as in (A) and evaluated at 24 hr for Akt phos- cell clones were able to proliferate when IL-3 was resup-
phorylation. plied following 5 days of growth factor withdrawal, a
time point at which no vector control cells could be
recovered (data not shown).were as susceptible as control cells to IL-3 withdrawal-
induced death (data not shown). When IL-3 was resup-
plied after 5 days of growth factor withdrawal, T22N 1
Inhibition of Rab7 Function Promotes Cellularand T22N 2 cells reentered the cell cycle and proliferated
Transformationwhile vector control cells did not (data not shown). Bcl-
One step in the process of transformation is escapeXL cells, included as a control, were also protected from
from the dependence on extrinsic growth factors. Asapoptosis following IL-3 withdrawal (Figure 5A).
interfering with Rab7 function resulted in a greater abilityIf Rab7 inhibition promotes cell survival by sustaining
of cells to maintain growth factor-independent nutrientnutrient uptake, then blocking Rab7 function should not
uptake, Rab7 functions to promote cell-autonomousprotect cells from apoptosis induced by nutrient limita-
growth. Thus, the ability of Rab7 T22N expression totion. We therefore tested the ability of Rab7 T22N to
promote colony formation by fibroblasts in soft agarprotect cells from amino acid or glucose withdrawal-
was examined. Colony formation in soft agar has beeninduced death (Figure 5B). Amino acid or glucose with-
well established to correlate closely with the ability todrawal resulted in cell death in vector control cells with
form tumors in vivo (Freedman and Shin, 1974; Li et al.,similar kinetics to IL-3 withdrawal. Although interfering
1989). Because transformation is a multi-step process,with Rab7 function protected cells from IL-3 withdrawal,
it was unlikely that the inhibition of Rab7 function aloneno resistance to amino acid or glucose withdrawal-
would result in transformation. The p53 protein plays aninduced death was observed in Rab7 T22N-expressing
important role in the suppression of cellular transforma-cells. In contrast, the antiapoptotic effects of Bcl-XL did
tion due to its proapoptotic activities (Vousden and Lu,not depend upon the presence of extracellular nutrients.
In order to confirm that the protective effect of Rab7 2002). For this reason, we evaluated whether blocking
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Figure 5. Blocking Rab7 Function Allows
IL-3-Independent, Nutrient-Dependent Cell
Survival
(A) Cells expressing the indicated transgenes
were withdrawn from IL-3 and cell viability
measured by propidium iodide exclusion and
flow cytometry.
(B) Vector control, Bcl-XL-expressing, or
Rab7 T22N-expressing cells were withdrawn
from amino acids or glucose and cell viability
measured by propidium iodide exclusion and
flow cytometry at the indicated time points.
One of at least three independent experi-
ments is shown.
Rab7 activity in p53-deficient cells would allow transfor- adenoviral E1A protein by retroviral transduction. Loss
of p53 and inhibition of Rb by E1A was inadequate tomation. Low-passage p53/ MEFs were stably trans-
fected with Rab7 T22N and sorted for high-EGFP ex- transform mouse embryonic fibroblasts (Figure 7). How-
ever, when Rab7 function was blocked by Rab7 T22Npression. When p53/ MEFs expressing empty vector
or high levels of Rab7 T22N were examined in soft agar expression, p53 null E1A-expressing MEFs formed colo-
nies in soft agar.assays, no colonies were formed (data not shown). In
addition to resisting apoptosis, transformation requires
the ability to enter the cell cycle in the absence of extrin- Discussion
sic signals. The tumor suppressor protein Rb plays an
important role in preventing cell-autonomous prolifera- In this report, we show that Rab7 plays a critical role in
the downregulation of cell surface nutrient transporterstion (Sherr, 2001). To inactivate Rb, we expressed the
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Figure 6. Alternate Means of Inhibiting Rab7 Function Also Support Growth Factor-Independent Cell Survival
(A) FL5.12 cells were transiently transfected with empty vector or a short DNA hairpin directed against murine Rab7 (mRab7) and Rab7 levels
evaluated by Western blot. As a control, canine Rab7 (cRab7) was transfected along with the short hairpin.
(B and C) A parallel sample of the cells evaluated in (A) was withdrawn from IL-3. Cell survival was measured by PI exclusion and flow
cytometry (B) and the mean FCS of live G1 cells determined at the 14 hr time point (C).
(D) FL5.12 cell lines stably expressing empty vector (VEC) or an EGFP-C33 RILP fusion protein were created and evaluated for transgene
expression by Western blot.
(E) Vector control and C33 RILP-expressing cells were withdrawn from IL-3 and cell viablility determined by PI exclusion and flow cytometry.
following growth factor withdrawal and thereby contrib- nutrient transporters were preserved. All of these param-
eters, however, were unaffected by the inhibition ofutes to the initiation of apoptosis. When cells are with-
drawn from growth factors, their ability to access extra- Rab7 function as long as growth factors were present
in the medium. Hence, Rab7 activity is dispensable forcellular nutrients is compromised by the degradation of
cell surface nutrient transporter proteins. By interfering normal cell growth but is instead involved in arresting
cell growth in the absence of growth factor support.with Rab7 function through the expression of a domi-
nant-negative mutant, Rab7 T22N, we blocked the deg- Consistent with this model, Rab7 is not an essential
gene in yeast, and the Rab7 transcript is induced inradation of glucose and amino acid transporter proteins.
Blocking Rab7-dependent transporter degradation ren- FL5.12 cells following IL-3 withdrawal (Wichmann et al.,
1992; and C. Fox, personal communication).dered FL5.12 cells IL-3 independent for nutrient uptake,
and many of the atrophic sequelae of growth factor Interfering with Rab7 function both through dominant-
negative protein expression and by RNAi not only main-withdrawal were prevented. 4EBP1 phosphorylation
was maintained, suggesting that the amino acid-sensi- tained a nutrient-replete phenotype following IL-3 with-
drawal but also promoted growth factor-independent,tive cell signaling pathways responsible for maintaining
4EBP1 phosphorylation were no longer inactivated. The nutrient-dependent cell survival. These results support
the conclusion that Rab7-dependent nutrient trans-catabolic cellular atrophy that is most likely a direct
consequence of decreased nutrient uptake was also porter downregulation plays a central role in the induc-
tion of growth factor withdrawal-induced apoptosis.blunted by inhibiting Rab7 function. Finally, m was
maintained in growth factor withdrawn cells in which Rab7 has no known function other than the regulation
of lysosomal membrane fusion reactions. Thus, it is un-Rab7 activity was blocked, indicating that mitochondrial
bioenergetics were better supported when cell surface likely that the protection from IL-3 withdrawal-induced
Rab7 Inhibits Cell-Autonomous Nutrient Uptake
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Figure 7. Transformation of p53/ MEFs by
E1A Is Enhanced by the Expression of Domi-
nant-Negative Rab7
p53/ MEFs stably expressing empty vector
(A) or high levels of Rab7 T22N (B) were trans-
duced with a retrovirus encoding E1A. In-
fected cells were selected for 2 days in puro-
mycin-containing medium at which point
100,000 cells were plated per 60 mm dish.
Plates were photographed after 30 days of
incubation. Size bar is 1 mm. (C) Colonies
formed on triplicate plates were counted and
classified according to colony diameter.
death that results from interfering with Rab7 function is Several proteins involved in the regulation of endocy-
tosis have been linked to cancer. TSC2/tuberin, a genedue to a mechanism unrelated to its effects on lysosomal
trafficking. Consistent with this, expression of a domi- deleted in the tumor-prone tuberous sclerosis syn-
drome, is reported to be a GAP for Rab5, a proteinnant-negative form of the downstream protein RILP re-
capitulated the cell survival phenotype observed when that regulates endosomal fusion reactions that occur
membrane proximal to those controlled by Rab7 (XiaoRab7 function was disrupted. Although the decreased
growth factor withdrawal-induced protein degradation et al., 1997). However, unlike Rab7 T22N, expression of
a dominant-negative Rab5 construct did not promoteobserved following Rab7 inhibition is not specific to
nutrient transporters, the observation that cells were still FL5.12 cell survival upon IL-3 withdrawal (data not
shown). This result is not inconsistent with our model.susceptible to apoptosis induced by nutrient withdrawal
demonstrates that increased nutrient access is an im- In order to support nutrient uptake, transporters must
be expressed on the cell surface. Inhibiting transporterportant component of the protective effect of blocking
Rab7 function. The most likely alternative hypothesis, degradation at a postendocytic step would not be pre-
dicted to increase cell survival unless transporter pro-that persistent growth factor signaling was maintained
when Rab7 was inhibited due to recycling of the IL-3- teins are also shunted into a recycling pathway and
reexpressed on the cell surface. While disrupting Rab7bound IL-3 receptor, was ruled out. Thus, our results are
most consistent with a model in which Rab7-dependent function results in efficient nutrient transporter recy-
cling, interfering with Rab5 function does not appear tonutrient transporter degradation initiates apoptosis fol-
lowing growth factor withdrawal and thereby prevents support a sufficient level of nutrient transporter surface
expression to maintain growth factor-independent cellcell-autonomous growth by mammalian cells.
Our results have implications for oncogenic progres- survival.
Mutations in several endocytic proteins promote cel-sion. Full transformation requires that cells suppress
cell-intrinsic apoptotic pathways and proliferate in the lular transformation by maintaining growth factor signal-
ing in the absence of ligand. Thus far, Rab7 T22N andabsence of extrinsic signals. Therefore, neoplastic
growth depends on the inactivation of the p53 and Rb Rab7 RNAi are unique in their ability to support cell
survival without preserving growth factor signaling.tumor suppressor proteins that induce apoptosis and
prevent cells from exiting the G1 phase of the cell cycle, Based on the results presented here, other proteins in-
volved in endocytosis and linked to cancer developmentrespectively, in the absence of growth factors (Sherr,
2001; Vousden and Lu, 2002). However, p53 deficiency should be evaluated for their abililty to support growth
factor-independent nutrient transporter expression. Forin combination with Rb inactivation by E1A was insuffi-
cient to promote colony formation by MEFs in soft agar example, chromosomal translocations involving three
different proteins involved in endocytosis are associated(Figure 7) or to allow tumor formation in nude mice (De-
genhardt et al., 2002). Thus, the ability to resist apoptosis with hematopoetic malignancies (Floyd and De Camilli,
1998), and overexpression of eps15, the murine orthologand to enter the cell cycle is not sufficient for transforma-
tion. As the inhibition of Rab7-dependent nutrient trans- of one of these fusion partners, promotes colony forma-
tion by NIH 3T3 cells in soft agar. It is likely that someporter degradation in p53 null, E1A-expressing cells did
result in colony formation in soft agar, the acquisition of these proteins promote transformation by maintaining
growth factor signaling pathways. However, in light ofof a mechanism for cell-autonomous nutrient uptake
may be a critical step in transformation. our findings with Rab7, the ability to support nutrient
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then incubated sequentially with primary and secondary antibodiestransporter expression should be considered as an alter-
for 1 hr at RT in wash buffer containing 0.3% saponin and 10%nate mechanism by which proteins in the endocytic
FCS. Live cells were stained in media containing LysoTracker Redpathway might promote transformation.
(Molecular Probes) at 50 nM for 30 min at 37C. Cells were examined
The human Rab7 gene is located on chromosome 3 using a Nikon E800 fluorescence microscope equipped with a CCD
(3q22.1). Deletions, insertions, inversions, and translo- camera or with a Biorad ES confocal microscope. Images were
analyzed using the Metamorph software package (epifluorescence)cations of this region of chromosome 3 have been identi-
or with LaserSharp (confocal).fied frequently in hematologic malignancies (Jotterand
Bellomo et al., 1992; Kashuba et al., 1997; Mitelman et
Flow Cytometryal., 1997; Wieser et al., 2001). Several other tumor types
For evaluation of 4F2hc surface expression, 500,000 cells wereare also characterized by genomic alterations in this
washed with wash buffer (PBS containing 2% FCS and 0.05% so-
region (Bodmer et al., 2002; Edstrom et al., 2000). The dium azide) and then incubated on ice for 15 min with 5 g of mouse
identity of the proposed tumor suppressor protein has immunoglobulin (Jackson Immunoresearch) to block Fc receptors.
Primary antibody (rat anti-mouse 4F2hc) was added at a 1:1000not yet been identified, although Rab7 has been shown
dilution in the presence of mouse immunoglobulin, and cells wereto be affected in at least one chromosomal rearrangement
incubated for 30 min on ice. After two washes with cold buffer,of this region (Kashuba et al., 1997). Analysis of primary
secondary antibody (donkey anti-rat Ig preabsorbed against mousehuman tumor cells will be important to clarify whether
immunoglobulin, Jackson Immunoresearch) coupled to R-phycoer-
Rab7 activity is decreased in naturally occurring tumors ytherin was added for 30 min. Cells were analyzed on a Becton
or whether other means of supporting nutrient uptake Dickinson FACS Calibur flow cytometer. For measurements of cell
viability and size, cells were incubated with 10 g/ml of both propid-are more commonly utilized by cancer cells. Once the
ium iodide and Hoechst 33342 for 30 min at 37C and then analyzedmechanisms by which primary tumor cells maintain nu-
on a Becton Dickinson LSR flow cytometer. Mitochondrial mem-trient uptake are identified, these pathways will repre-
brane potential was evaluated by incubating 500,000 cells with 10sent novel, unexplored potential targets for chemothera-
nM TMRE (Molecular Probes) for 30 min at 37C prior to analysis
peutic intervention. As angiogenesis inhibitors work on using the LSR cytometer. CCCP (50 M) and chloroquine (4 g/ml)
the principle of nutrient limitation, it is possible that were added to duplicate tubes to determine background and con-
firm that TMRE fluorescence was lost upon the dissipation of m.drugs that stimulate transporter internalization and deg-
radation would be similarly effective.
Western Blotting
Cells were washed with PBS and lysed in RIPA-containing proteaseExperimental Procedures
(Complete, Roche) and phosphatase (Phosphatase Inhibitor Cock-
tail Set 1, Calbiochem) inhibitors. Lysates were cleared by centrifu-Materials and Constructs
gation and equal amounts of total cell protein were loaded ontoAntibodies were purchased from Santa Cruz Biotechnologies (Rab7,
Tris-glycine SDS PAGE gels (Invitrogen). Proteins were transferredPim-1, and actin); Clontech (EGFP); Cell Signaling Technologies
to nitrocellulose, the membrane blocked with BLOTTO (5% nonfat(Akt, phospho-Akt Ser473, phospho-4EBP, 4EBP, and anti-rabbit
dry milk and 0.1% Tween-20 in PBS), and incubated with the indi-HRP); BD Pharmingen (4F2hc and Lamp-1); Research Diagnostics,
cated antibodies prior to probing with ECL (Amersham Pharmacia).Inc (Glut1); and Affinity Bioreagents (phospho-Akt Thr308). The
A modified sample buffer (250 mM Tris, 5% SDS, 8 M urea, 0.16 Msheep serum used to immunoprecipitate Glut1 was generously pro-
DTT for 2.5X) and incubation at 37C for 15 min were used whenvided by Dr. Morrie Birnbaum (University of Pennsylvania). Propid-
lysates were to be probed for Glut1 to avoid Glut1 aggregation.ium iodide, Hoechst 33342, and Alexa594 anti-rat secondary were
Glut1 levels were quanitified using the Scion Image software.from Molecular Probes. The bicinchoninic acid protein assay kit
(Pierce) was used to determine total protein in cell lysates. EGFP-
Endoglycosidase DigestionRab7 (canine), EGFP-Rab7 T22N (canine), and EGFP-C33 RILP (hu-
Glut1 was immunoprecipitated from 100 g of total cell lysate. Im-man) were obtained from Dr. Cecilia Bucci (Universita di Napoli,
munoprecipitates were resuspended in denaturing buffer and incu-Italy) and cloned into the EF6/V5-HIS mammalian expression vector
bated at 37C for 10 min after which DTT and NP-40 were added(Invitrogen). Rab5 and Rab5 S34N were generously provided by Dr.
per the manufacturers instructions. One unit of Endo F was addedPhil Stahl (Washington University, St. Louis).
and reactions incubated at 37C for 1 hr; control reactions wereThe pKD vector used to express short hairpins for RNAi was
prepared in the same manner but incubated without enzyme. Reac-derived from pBabe-Puro by deleting a portion of the 3 LTR. The
tions were stopped by the addition of modified sample buffer andhuman U6 RNA polymerase III promoter (265 to 1) was PCR
changes in glycosylation pattern monitored by Western blot.amplified from HeLa genomic DNA and TA cloned into pEF6/V5-
HIS generating pEF6-hU6. To generate short hairpin RNAs (shRNA)
for RNA interference, a PCR-based strategy was employed using Soft Agar Assays
pEF6-hU6 as a template and primers containing the DNA hairpin p53/ MEFs were stably transfected with EGFP-Rab7 T22N and
sequence as previously described (Paddison and Hannon, 2002). then sorted on a MoFlow Cytomation cell sorter to obtain a popula-
The resultant PCR product (330 bp) was TOPO-TA cloned into pEF6/ tion of cells with elevated EGFP fluorescence. Cells were transduced
V5-HIS, hairpin sequence in the correct orientation excised with with an MLV-based retroviral vector encoding E1A and then selected
EcoRV and BamHI and ligated into the SnaBI and BamHI sites of in 1 mg/ml puromycin for 2 to 3 days prior to plating. One hundred
pKD. The Rab7 hairpin sequence (sense) is 5GGG GGA CTC TGG thousand live cells were plated in 60 mm dishes in complete medium
TGT TTG GAA A 3. containing 0.38% Noble agar (Difco) layered over a base of 0.6%
agar in medium. Plates were incubated for 21 to 30 days at 37C in
a humidified CO2 incubator, at which point colonies were countedCell Culture
and photographed.FL5.12 cells were maintained in RPMI (Gibco) supplemented with
10% FCS (Gemini), 8% WEHI-conditioned medium, 10 mM HEPES,
55 M -mercaptoethanol, antibiotics, and L-glutamine. Glucose or Acknowledgments
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